A 12-week RCT has shown that healthy individuals consuming a microalga-based omega-3 supplement had seen a 25% drop in very-low-density lipoprotein (VLDL) and 3% drop in total cholesterol (TC) level.
Companies and research institutes are having to put on hold or postpone their non-COVID-19 clinical trials due to movement control orders and public health resources prioritising the fight against COVID-19.
A trial involving healthy Japanese men has shown for the first time that a single dose of nicotinamide mononucleotide (NMN) is safe for consumption and is effectively metabolised by the body.
Gencor Pacific is embarking on a human trial in Australia to validate the immunity boosting ability of Palmitoylethanolamide (PEA) against the backdrop of the rising demand for immunity supplements amid the worldwide spread of COVID-19.
Drinking whey protein-infused carbohydrate beverage pre-operation and starting on an early oral feeding post-operation can shorten hospital stay and preserve muscle mass, according to a Malaysia RCT.
An extract from dahlia petals has shown benefits for reversing diabetic symptoms and researchers from New Zealand will now embark on a four-week human clinical trial to validate previous findings.
Consuming Korean dang-gui (angelica gigas nakai) for 12 weeks could help reduce blood triglyceride levels, according to a randomised placebo-controlled trial that took place in South Korea.
An ayurvedic botanical-based ingredient has shown to reduce the symptoms of knee osteoarthritis, including knee pain and stiffness, according to an eight-week trial involving Indian participants.
Australian researchers are looking into the effects omega-3 intake on aggressive behaviour in male prison inmates, with a multi-centre trial in six correctional centres commencing this year.
Omega-3 intervention trials must be vastly improved using accurate data from Omega-3 Index testing, so more precise and personalised approaches to treatment can be adopted.
Blackmores' practitioner-only firm BioCeuticals is investing heavily in medicinal cannabis research, recently announcing its $500,000-plus funding of the world's first clinical trial to investigate its effects on brain tumours and the symptoms...
Experts gathered to discuss the potential and developments in the probiotics industry, highlighting regulations, trial design and costs as three areas to pay attention to in improving the industry's prospects.